Cargando…
Quantifying survival in Patients with Proteus Syndrome
PURPOSE: Proteus syndrome is a rare mosaic overgrowth disorder that is associated with severe complications. While anecdotal data have suggested that the lifespan of affected patients is reduced, this has not been measured. Mortality data on rare diseases is critical for assessing treatments and oth...
Autores principales: | Sapp, Julie C., Hu, Lian, Zhao, Jean, Gruber, Ashlyn, Schwartz, Brian, Ferrari, Dora, Biesecker, Leslie G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720922/ https://www.ncbi.nlm.nih.gov/pubmed/28661492 http://dx.doi.org/10.1038/gim.2017.65 |
Ejemplares similares
-
Cardiothoracic imaging findings of Proteus syndrome
por: Mirmomen, S. Mojdeh, et al.
Publicado: (2021) -
Development of the Clinical Gestalt Assessment: a visual clinical global impression scale for Proteus syndrome
por: Ours, Christopher A., et al.
Publicado: (2022) -
Case report: five-year experience of AKT inhibition with miransertib (MK-7075) in an individual with Proteus syndrome
por: Ours, Christopher A., et al.
Publicado: (2021) -
Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome
por: Lindhurst, Marjorie J., et al.
Publicado: (2015) -
Clinical report: one year of treatment of Proteus syndrome with miransertib (ARQ 092)
por: Biesecker, Leslie G., et al.
Publicado: (2020)